ALFA Filings
Every announcement, straight from the exchange
Every Marksans Pharma other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Periodic quarterly shareholding pattern filing for Marksans Pharma Ltd. This document provides the latest breakdown of shareholder categories as mandated by SEBI.
Marksans Pharma intimated shareholders about SEBI's extended special window (Feb 2026–Feb 2027) for re-lodgement of pre-April-2019 physical share transfer deeds. No new business, capital, or operational event is disclosed.
Marksans Pharma Ltd. has received an ESG score of 56 from Crisil ESG Ratings & Analytics Ltd for Fiscal 2026.
Marksans Pharma Ltd filed its quarterly shareholding pattern as per Regulation 31(1)(b). The report details equity distribution among promoters, institutions, and public shareholders.
Marksans Pharma submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The auditor confirmed compliance with SEBI regulations and secretarial standards.